Nephrology

The integration of novel AKI biomarkers into risk-stratification algorithms both at single and longitudinal time points in new populations; Outcome studies from novel devices aimed to improve outcomes for patients with AKI and multiorgan failure

The program consists of engaging lectures with relevant case presentations by experts; there will be discussions and analysis of the pre-assignment documents and demonstration of good documentation practices, including voice recognition technology; and a Q&A session where individual questions are addressed